Morben Paul Keith sold $107K of OSIS
Morben Paul Keith (PRES., OPTOELECTRONICS DIV) sold 536 shares of OSI SYSTEMS INC (OSIS) at $200.00 ($0.11M total) on 2026-11-09.
OSI SYSTEMS INC
OSI Systems designs and manufactures specialized electronic systems and components for critical applications, selling products and related services in security, healthcare, defense and aerospace markets. Its three divisions are Security, which provides inspection systems, screening services and high-power radio frequency systems; Optoelectronics and Manufacturing, which supplies electronic components, subsystems and manufacturing services; and Healthcare, which offers patient monitoring, cardiology, remote monitoring and connected care products. Security products are sold primarily to end users, including government agencies, airports and other facilities, under the Rapiscan name; screening services include checkpoint staffing and operations under the S2 name. Healthcare products, sold mainly to end users under the Spacelabs Healthcare name, include monitoring devices, software, accessories and support services. Optoelectronics and manufacturing services are provided primarily to original equipment manufacturer customers, through brands including OSI Optoelectronics, OSI Electronics, Altaflex and PFC Flexible Circuits. OSI Systems is headquartered in Hawthorne, California.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $OSIS in the last 7 days.
Morben Paul Keith (PRES., OPTOELECTRONICS DIV) sold 536 shares of OSI SYSTEMS INC (OSIS) at $200.00 ($0.11M total) on 2026-11-09.
OSI Systems' Spacelabs Healthcare unit is investing £8.7 million in its Edinburgh R&D hub, creating 30 new roles. The project, supported by a £3.1 million Scottish Enterprise grant, aims to develop next-generation patient monitoring technologies. The expansion will increase Spacelabs' Edinburgh team from 22 to 52 people, focusing on software engineering and cybersecurity.
OSI SYSTEMS INC (OSIS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 OSI SYSTEMS REPORTS FISCAL 2027 FIRST QUARTER FINANCIAL RESULTS · Record Q1 Revenues of $403 Million · Record Q1 Earnings per Diluted Share o GAAP EPS of $1.51 (28% year-over-year growth) o Non-GAAP EPS of $1.66 (17% year-over-year growth) · Book-to-Bill Ratio of 1.4
Recent OSIS coverage spans earnings, financial news and insider activity.
In the last 30 days, OSIS insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($107K). The most active reporter was Morben Paul Keith, PRES., OPTOELECTRONICS DIV, with 1 filing.
Insider sale by a senior officer may signal modest downside pressure.
The modest capital outlay is unlikely to move the stock immediately but signals longer‑term growth in the patient‑monitoring segment.
Positive earnings surprise with raised guidance.
Guidance raise and record earnings suggest upside pressure on the stock.
Downward pressure from a weak quarter.
AlphAI scores every news story that mentions OSIS with an AI model for sentiment and relevance, and aggregates insider trades from OSI SYSTEMS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Morben Paul Keith (PRES., OPTOELECTRONICS DIV) sold 536 shares of OSI SYSTEMS INC (OSIS) at $200.00 ($0.11M total) on 2026-11-09.
OSI Systems' Spacelabs Healthcare unit is investing £8.7 million in its Edinburgh R&D hub, creating 30 new roles. The project, supported by a £3.1 million Scottish Enterprise grant, aims to develop next-generation patient monitoring technologies. The expansion will increase Spacelabs' Edinburgh team from 22 to 52 people, focusing on software engineering and cybersecurity.
OSI SYSTEMS INC (OSIS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 OSI SYSTEMS REPORTS FISCAL 2027 FIRST QUARTER FINANCIAL RESULTS · Record Q1 Revenues of $403 Million · Record Q1 Earnings per Diluted Share o GAAP EPS of $1.51 (28% year-over-year growth) o Non-GAAP EPS of $1.66 (17% year-over-year growth) · Book-to-Bill Ratio of 1.4
OSI Systems (OSIS) reported record Q1 FY27 revenue and earnings per share, with $583M in bookings and a backlog of $2.1B. The company raised its FY27 non-GAAP EPS guidance while maintaining revenue guidance.
Napco (ARLO) reported Q2 revenues of $55.81M, up 10% YoY, beating estimates. OSI Systems (OSIS) reported $484.1M, down 4.1% YoY, missing estimates. PAR Technology (PAR) reported $133.4M, up 18.7% YoY, beating estimates. Cognex (CGNX) reported $291.3M, up 16.9% YoY, missing revenue estimates but beating EPS guidance. Stocks reacted accordingly.
OSI Systems Inc. (OSIS) is set to report fiscal Q1 earnings, with analysts expecting $1.64 EPS on $396.95M revenue. Recent contract wins are under scrutiny as investors seek evidence of revenue growth after a prior miss. Six of seven analysts rate it a buy, with a mean target of $273.29, implying 40% upside. The company's Security division's pipeline and margin sustainability are key focuses.
PAR Technology (NYSE:PAR) stock fell 5.6% post-earnings. OSI Systems (NASDAQ:OSIS) missed revenue and guidance, dropping 9.9%. Arlo Technologies (NYSE:ARLO) beat estimates but fell 19.7%. Zebra (NASDAQ:ZBRA) beat expectations, rising 28.1%.
Napco (NSSC) stock fell 22.6% post-earnings, trading at $11.97. OSI Systems (OSIS) reported $484.1M revenue, down 4.1% YoY, missing estimates, and stock dropped 11.9% to $192.03. PAR Technology (PAR) saw 18.7% revenue growth, beating estimates, but stock fell 6.9% to $15.94. Zebra (ZBRA) reported $1.56B revenue, up 20.4% YoY, and stock rose 28.7% to $375.38.
Zebra (ZBRA) reported Q2 revenues of $55.81M, up 10% YoY, beating estimates. Stock is down 5% since reporting. OSI Systems (OSIS) reported $484.1M revenue, down 4.1% YoY, missing estimates. Stock is down 10.6%. Mirion (MIR) reported $266.8M revenue, up 19.7% YoY, mixed results. Stock is flat. Crane NXT (CXT) reported $493.2M revenue, up 22% YoY, beating estimates. Stock is down 3.7%.
OSI Systems (OSIS) reported $1.79B revenue and $276M operating cash flow for fiscal 2026, with $359.8M in cash. It secured $90M in US government contracts and plans to expand capacity. Revenue grew 5% in Optoelectronics and margins improved in Healthcare. Non-GAAP EPS grew 11% to $10.35, while GAAP EPS was $8.95. Fiscal 2027 guidance projects 5-8.1% revenue growth and 7.5-11% EPS growth.